Thalia Therapeutics Plc (0GO)
Market Closed
12 Aug, 20:00
XFRA XFRA Primary 
LSE €
0. 01
0
0%
€
416.14K Market Cap
- P/E Ratio
- Div Yield
225 Volume
- Eps
€ 0.01
Previous Close Want to track 0GO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Thalia Therapeutics Plc (0GO) Statistics
Valuation metrics
Market Cap 416.14K
Enterprise value -1.66M
Trailing P/E (ttm) -0.16
Forward P/E -
PEG ratio -
Price/Sales (ttm) 58.89
Price/Book (mrq) 0.14
Enterprise Value/Revenue -203.59
Enterprise Value/EBITDA 1.43
Overview
Shares outstanding 832.28M
Float 370.24M
Shares short -
% Held by insiders 0.38%
% Held by institutions -
Average volume (10 days) 475
Average volume (90 days) 1.27K
Price summary
52-Week low 0
52-Week high 0.03
Beta 0.71
50-Day moving average 0
200-Day moving average 0
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -
Operating margin -127.43%
Operational effectiveness
Return on assets -0.47%
Return on equity -0.74%
Income Statement
Revenue (ttm) 8.17K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -0.06%
Gross profit (ttm) 8.17K
EBITDA -
Net income to common (ttm) -1.28M
Diluted EPS (ttm) -0
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2M
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 23.55%
Book value per share (mrq) 0
Cash Flow
Cash flow statement -1.19M
Levered free cash flow (LFCF) -816.05K
